Myong Hwa Yamamoto

Myong Hwa Yamamoto

Auto-generated profile, based on publicly available information

Myong Hwa Yamamoto


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2024 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
SNShuro Narui
Shuro Narui
MYMyong Hwa Yamamoto
Myong Hwa Yamamoto
HMHiroyoshi Mori
Hiroyoshi Mori
KAKisaki Amemiya
Kisaki Amemiya
TOToshitaka Okabe
Toshitaka Okabe
MOMasahiko Ochiai
Masahiko Ochiai

5 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ITIORI TAKI
IORI TAKI
TYTaigi Yamazaki Taigi Yamazaki
Taigi Yamazaki Taigi Yamazaki
NTNobuyuki Takahashi
Nobuyuki Takahashi
MYMyong Hwa Yamamoto
Myong Hwa Yamamoto
ATAkiko Toju
Akiko Toju
NHNoriko Hida
Noriko Hida
Background/Objectives: The use of food thickeners with ciprofloxacin tablets may result in a gelatinous appearance and experience delayed dissolution, which presents a challenge for the drug’s efficacy, creating a healthcare economic issue. However, the pharmacokinetic impact of this compound in humans remains uncertain. Therefore, a comparative pharmacokinetic study of ciprofloxacin was conducted on healthy adult Japanese males. Methods: We compared the effects of administering tablets with water or thickened water and crushed tablets mixed with thickened water. The maximum blood concentration (Cmax) of ciprofloxacin determines the drug’s efficacy. Results: There were variations in drug absorption across different administration methods. The group who took the tablets immersed in thickened water exhibited different results in the area under the blood drug concentration–time curve (AUC) and Cmax compared to the group who took the tablets in regular water. Notably, the group that consumed the crushed tablets mixed with thickened water demonstrated equivalent results for both AUC and Cmax. Conclusions: Administering crushed tablets in thickened water may yield pharmacokinetics comparable to those of tablets taken with water. However, the process of crushing tablets may result in the loss of active ingredients and compromise the formulation, necessitating a comprehensive assessment before administration.

1 January 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SNShuro Narui
Shuro Narui
MYMyong Hwa Yamamoto
Myong Hwa Yamamoto
HMHiroyoshi Mori
Hiroyoshi Mori
KAKisaki Amemiya
Kisaki Amemiya
TOToshitaka Okabe
Toshitaka Okabe
MOMasahiko Ochiai
Masahiko Ochiai
Background Percutaneous coronary intervention (PCI) for lesions with calcified nodules (CNs) is associated with worse outcomes than PCI for other calcified lesions. We aimed to clarify the relationship between CNs at index PCI, optical coherence tomography (OCT) findings at 8-month follow-up, and clinical outcomes using serial OCT. Methods This retrospective observational study utilized data from a prospective, single-center registry. We conducted consecutive PCI for calcified lesions requiring rotational atherectomy (RA) with OCT guidance. We categorized 51 patients (54 lesions) into those with (16 patients [16 lesions]) and without CNs (35 patients [38 lesions]). Results Post-PCI, stent expansion was comparable between the two groups, and CN-like protrusion was observed in 75% of patients in the CN group. Follow-up OCT at 8 months revealed in-stent CNs in 54% of treated CN lesions with CN-like protrusion, whereas non-CN lesions lacked in-stent CNs. The CN group exhibited greater maximum neointimal tissue (NIT) thickness than the non-CN group (p180°. Conclusions Following RA treatment with acceptable stent expansion, the presence of CNs before PCI correlated with greater neointimal tissue formation with in-stent CNs, resulting in a higher TLR rate, especially in lesions with maximum CN angles exceeding 180°. What is Known Calcified lesions with calcified nodules (CNs) are associated with a higher target lesion revascularization (TLR) rate in percutaneous coronary intervention (PCI) than other types of calcified lesions. In-stent CNs may appear after PCI for CNs and is a major cause of increased TLR rates after PCI for CNs. The relationship between calcified plaque morphology at the index PCI, neointimal tissue characteristics concerning in-stent CN location and frequency during follow-up, and subsequent clinical outcomes has not been explored with serial optical coherence tomography. What the Study Adds Follow-up OCT at 8 months revealed in-stent CNs in 54% of treated CN lesions with CN-like protrusion, whereas non-CN lesions lacked in-stent CNs. PCI for CNs exhibited a higher clinically-driven target lesion revascularization rate than PCI for lesions without CNs, primarily in lesions with maximum CN angles >180°.